Table 2.
Blood levels of FBG, HbA1c, adiponectin, leptin and lipid profiles at baseline and at the end of the study.
| Parameters | Placebo (n = 18) | Probiotic (n = 18) | ||||
|---|---|---|---|---|---|---|
| Wk-0 | Wk-12 | p-Value | Wk-0 | Wk-12 | p-Value | |
| FBG (mg/dL) | 139.29 ± 49.77 | 149.12 ± 47.42 | 0.208 a | 129.18 ± 34.52 | 109.35 ± 15.56 | 0.005 a |
| HbA1c (%) | 6.64 ± 1.44 | 6.73 ± 1.29 | 0.837 a | 7.05 ± 1.85 | 6.46 ± 1.49 | 0.145 a |
| Adiponectin (ng/mL) | 27.70 ± 7.26 | 24.03 ± 12.52 | 0.465 b | 23.40 ± 8.75 | 30.73 ± 18.40 | 0.763 b |
| Leptin (ng/mL) | 15.56 ± 13.56 | 26.46 ± 8.49 | 0.095 b | 15.74 ± 9.51 | 14.60 ± 8.70 | 0.345 b |
| TG (mg/dL) | 147.78 ± 71.32 | 159.50 ± 67.87 | 0.581 a | 153.27 ± 55.46 | 144.53 ± 58.68 | 0.560 a |
| Cholesterol (mg/dL) | 190.83 ± 43.22 | 184.94 ± 46.65 | 0.314 a | 188.59 ± 34.21 | 182.88 ± 30.38 | 0.453 a |
| LDL (mg/dL) | 102.11 ± 32.60 | 90.61 ± 16.06 | 0.106 a | 109.24 ± 38.44 | 81.47 ± 33.53 | <0.00 a |
| HDL (mg/dL) | 62.87 ± 9.83 | 68.67 ± 13.99 | 0.145 a | 62.06 ± 14.84 | 72.06 ± 21.34 | 0.026 a |
Data are mean ± SD. Difference between baseline and the end of study for the within group comparisons. a p-value obtained from paired t-test, b p-value obtained from Wilcoxon signed rank test.